Amy L. McLaren Ultragenyx Pharmaceutical

Amy McLaren is a Senior Director of Quality and Compliance at Ultragenyx Pharmaceuticals and heads Global Health Authority Inspection Management and Risk Management.  Amy is a seasoned Clinical Research and Quality professional with 23 years of experience in a variety of indications including Neurology, Oncology and Rare Disease.  Throughout her career, she has managed Phase II and pivotal Phase III Clinical Programs and led cross-funtional teams and sites across the globe through the process of Regulatory Agency Inspection.

Amy’s experience has taught her the importance of both technical expertise and emotional intelligence as it relates to individual and team performance. Being an effective leader in today’s world is complex. Over the course of her career, she has experienced the evolution of the workforce. Today’s talented professionals demand leaders to be engaging and inspiring – while cultivating teams where diverse skill-sets and perspectives are not only welcomed, but leveraged.  Amy brings to her organization an eye for continuous improvement and believes that a balance between structured framework and creativity is necessary for people to do their best work.

Amy is a 300-Hour Certified Mindfulness Meditation Teacher, holds her Yellow Belt in Kaizen and received her BS from Temple University in Kinesiology.